-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Initiates Coverage On Viking Therapeutics with Buy Rating, Announces Price Target of $94

Benzinga·10/15/2026 21:05:41
语音播报
UBS analyst Joon Lee initiates coverage on Viking Therapeutics (NASDAQ:VKTX) with a Buy rating and announces Price Target of $94.